Targeting oxidative stress in embryonal rhabdomyosarcoma.

Cancer Cell 2013 Dec;24(6):710-24

Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address:

Rhabdomyosarcoma is a soft-tissue sarcoma with molecular and cellular features of developing skeletal muscle. Rhabdomyosarcoma has two major histologic subtypes, embryonal and alveolar, each with distinct clinical, molecular, and genetic features. Genomic analysis shows that embryonal tumors have more structural and copy number variations than alveolar tumors. Mutations in the RAS/NF1 pathway are significantly associated with intermediate- and high-risk embryonal rhabdomyosarcomas (ERMS). In contrast, alveolar rhabdomyosarcomas (ARMS) have fewer genetic lesions overall and no known recurrently mutated cancer consensus genes. To identify therapeutics for ERMS, we developed and characterized orthotopic xenografts of tumors that were sequenced in our study. High-throughput screening of primary cultures derived from those xenografts identified oxidative stress as a pathway of therapeutic relevance for ERMS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2013.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904731PMC
December 2013
108 Reads

Publication Analysis

Top Keywords

oxidative stress
8
study high-throughput
4
pathway associated
4
ras/nf1 pathway
4
mutations ras/nf1
4
associated intermediate-
4
sequenced study
4
embryonal rhabdomyosarcomas
4
high-risk embryonal
4
intermediate- high-risk
4
tumors mutations
4
alveolar tumors
4
structural copy
4
primary cultures
4
embryonal tumors
4
analysis embryonal
4
screening primary
4
copy number
4
rhabdomyosarcomas erms
4
variations alveolar
4

Similar Publications